View in EDS

ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models.

Saved in:
Bibliographic Details
Title: ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models.
Authors: Zhang L; Authors' Affiliation: Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Castanaro C, Luan B, Yang K, Fan L, Fairhurst JL, Rafique A, Potocky TB, Shan J, Delfino FJ, Shi E, Huang T, Martin JH, Chen G, Macdonald D, Rudge JS, Thurston G, Daly C
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2014 May; Vol. 13 (5), pp. 1345-55. Date of Electronic Publication: 2014 Mar 14.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24634416
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Authors' Affiliation: Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Castanaro+C%22">Castanaro C</searchLink><br /><searchLink fieldCode="AU" term="%22Luan+B%22">Luan B</searchLink><br /><searchLink fieldCode="AU" term="%22Yang+K%22">Yang K</searchLink><br /><searchLink fieldCode="AU" term="%22Fan+L%22">Fan L</searchLink><br /><searchLink fieldCode="AU" term="%22Fairhurst+JL%22">Fairhurst JL</searchLink><br /><searchLink fieldCode="AU" term="%22Rafique+A%22">Rafique A</searchLink><br /><searchLink fieldCode="AU" term="%22Potocky+TB%22">Potocky TB</searchLink><br /><searchLink fieldCode="AU" term="%22Shan+J%22">Shan J</searchLink><br /><searchLink fieldCode="AU" term="%22Delfino+FJ%22">Delfino FJ</searchLink><br /><searchLink fieldCode="AU" term="%22Shi+E%22">Shi E</searchLink><br /><searchLink fieldCode="AU" term="%22Huang+T%22">Huang T</searchLink><br /><searchLink fieldCode="AU" term="%22Martin+JH%22">Martin JH</searchLink><br /><searchLink fieldCode="AU" term="%22Chen+G%22">Chen G</searchLink><br /><searchLink fieldCode="AU" term="%22Macdonald+D%22">Macdonald D</searchLink><br /><searchLink fieldCode="AU" term="%22Rudge+JS%22">Rudge JS</searchLink><br /><searchLink fieldCode="AU" term="%22Thurston+G%22">Thurston G</searchLink><br /><searchLink fieldCode="AU" term="%22Daly+C%22">Daly C</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2014 May; Vol. 13 (5), pp. 1345-55. <i>Date of Electronic Publication: </i>2014 Mar 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24634416
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-13-1033
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1345
    Titles:
      – TitleFull: ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Castanaro C
      – PersonEntity:
          Name:
            NameFull: Luan B
      – PersonEntity:
          Name:
            NameFull: Yang K
      – PersonEntity:
          Name:
            NameFull: Fan L
      – PersonEntity:
          Name:
            NameFull: Fairhurst JL
      – PersonEntity:
          Name:
            NameFull: Rafique A
      – PersonEntity:
          Name:
            NameFull: Potocky TB
      – PersonEntity:
          Name:
            NameFull: Shan J
      – PersonEntity:
          Name:
            NameFull: Delfino FJ
      – PersonEntity:
          Name:
            NameFull: Shi E
      – PersonEntity:
          Name:
            NameFull: Huang T
      – PersonEntity:
          Name:
            NameFull: Martin JH
      – PersonEntity:
          Name:
            NameFull: Chen G
      – PersonEntity:
          Name:
            NameFull: Macdonald D
      – PersonEntity:
          Name:
            NameFull: Rudge JS
      – PersonEntity:
          Name:
            NameFull: Thurston G
      – PersonEntity:
          Name:
            NameFull: Daly C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2014 May
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1